Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Off the Beaten Path: 3 Delisted Stocks for The Speculative Investor

By Josh Enomoto, InvestorPlace Contributor

While getting kicked off an exchange typically signals about the biggest warning sign you can possibly receive, a (somewhat) rational argument exists for delisted stocks…

7 Compelling Stocks to Buy That are Sitting at 52-Week Lows

By Josh Enomoto, InvestorPlace Contributor

In arguably most circumstances, when you see stocks at 52-week lows, you should avoid them. Based on prevailing market theory, equity valuations culminate from the…

Black Friday Winners: 7 Retail Stocks Set for Post-Holiday Gains

By Josh Enomoto, InvestorPlace Contributor

Given so much talk about stubbornly elevated inflation and soaring borrowing costs, it’s not surprising that retail stocks incurred much skepticism throughout this year. However,…

Twilio Layoffs 2023: What to Know About the Latest TWLO Job Cuts

By Josh Enomoto, InvestorPlace Contributor

Although the third round of Twilio layoffs may buy some time, activist investors of TWLO stock may be seeking bigger changes.

Why Is Alterity Therapeutics (ATHE) Stock Up 150% Today?

By Josh Enomoto, InvestorPlace Contributor

Although Alterity Therapeutics revealed encouraging data with its PD therapeutic candidate, ATHE stock still faces challenges.

3 January Effect Stocks to Buy Right Now

By Josh Enomoto, InvestorPlace Contributor

If you believe in the power of seasonal trends, the concept of The January Effect stocks might pique your interest. Fundamentally, the hypothesis suggests that…

Small Stakes, Big Rewards: 3 Penny Stocks with 300% Upside Potential

By Josh Enomoto, InvestorPlace Contributor

If the first rule in the film “Fight Club” is to not talk about fight club, then the same rule applies to penny stocks with…

Silent Winners: 7 Low-Buzz Stocks With High Potential

By Josh Enomoto, InvestorPlace Contributor

In many, if not most cases, you want to avoid betting on the same horse, which makes the concept of hidden-gem stocks quite compelling. Generally,…

Investor Favorites: 7 Dividend Stocks with Strong Buy Ratings

By Josh Enomoto, InvestorPlace Contributor

If you’re looking for the most confidence-inspiring ideas ahead of market ambiguities, don't overlook strong-buy dividend stocks.

NEXI Stock Halted: What’s Going on With NexImmune Shares Today?

By Josh Enomoto, InvestorPlace Contributor

NexImmune faces a likely dissolution of its business. Ahead of a key shareholder meeting, NEXI stock is halted.

Load More